Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
Vose JM, Bierman PJ, Ruby E, Reed EC, Bishop MR, Tarantolo S, Kessinger A, Armitage JO. Vose JM, et al. Among authors: kessinger a. Bone Marrow Transplant. 1996 Jun;17(6):951-6. Bone Marrow Transplant. 1996. PMID: 8807099 Clinical Trial.
Blood stem cell transplantation in non-Hodgkin's lymphoma.
Bishop MR, Kessinger A. Bishop MR, et al. Among authors: kessinger a. Cancer Invest. 1997;15(2):138-42. doi: 10.3109/07357909709115766. Cancer Invest. 1997. PMID: 9095209 Review. No abstract available.
Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies.
Pavletic ZS, Bishop MR, Tarantolo SR, Martin-Algarra S, Bierman PJ, Vose JM, Reed EC, Gross TG, Kollath J, Nasrati K, Jackson JD, Armitage JO, Kessinger A. Pavletic ZS, et al. Among authors: kessinger a. J Clin Oncol. 1997 Apr;15(4):1608-16. doi: 10.1200/JCO.1997.15.4.1608. J Clin Oncol. 1997. PMID: 9193360
A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantation.
Haire WD, Ruby EI, Stephens LC, Reed E, Tarantolo SR, Pavletic ZS, Bierman PJ, Bishop M, Kessinger A, Vose J, Armitage JO. Haire WD, et al. Among authors: kessinger a. Biol Blood Marrow Transplant. 1998;4(3):142-50. doi: 10.1053/bbmt.1998.v4.pm9923412. Biol Blood Marrow Transplant. 1998. PMID: 9923412 Free article. Clinical Trial.
227 results